Clinical trial
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
NCT00284856 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00284856 |
|---|---|
| Title | Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Parallel-Group 6-Month Study to Evaluate the Efficacy and Safety of Oral Montelukast Sodium, Fluticasone Propionate and Placebo in Patients With Chronic Asthma Who Smoke Cigarettes |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | montelukast sodium, Comparator: Placebo, Comparator: fluticasone |
| Enrollment | 1,640 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Feb 1, 2006 |
| Last update posted | May 10, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: